AtriCure, Inc, a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, announced...
Pulse Biosciences, Inc, a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation technology, announced that it has received the Breakthrough Device Designation...
Boston Scientific Corporation has initiated the AVANT GUARD clinical trial to evaluate the safety and effectiveness of the FARAPULSE Pulsed Field Ablation (PFA) System*...
Physicians and staff from Capital Health's Heart and Vascular Institute recently performed their first Watchman implant procedure at Capital Health Regional Medical Center in...
Lohman Technologies recently announced the release of their 2.0, next-generation, HomECG+ product. The FDA-cleared, clinical-grade remote monitoring solution for atrial fibrillation (AFib) detection is...
